These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 34968171)
1. Paper-based microfluidic chip for rapid detection of SARS-CoV-2 N protein. Sun M; Han M; Xu S; Yan K; Nigal G; Zhang T; Song B Bioengineered; 2022 Jan; 13(1):876-883. PubMed ID: 34968171 [TBL] [Abstract][Full Text] [Related]
2. Protein-based lateral flow assays for COVID-19 detection. Mahmoudinobar F; Britton D; Montclare JK Protein Eng Des Sel; 2021 Feb; 34():. PubMed ID: 33991088 [TBL] [Abstract][Full Text] [Related]
3. Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels. Ray P; Ledgerwood-Lee M; Brickner H; Clark AE; Garretson A; Graham R; Van Zant W; Carlin AF; Aronoff-Spencer ES Viruses; 2024 Apr; 16(5):. PubMed ID: 38793544 [TBL] [Abstract][Full Text] [Related]
4. Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA. Kasetsirikul S; Umer M; Soda N; Sreejith KR; Shiddiky MJA; Nguyen NT Analyst; 2020 Nov; 145(23):7680-7686. PubMed ID: 32975254 [TBL] [Abstract][Full Text] [Related]
5. Reciprocating-flowing on-a-chip enables ultra-fast immunobinding for multiplexed rapid ELISA detection of SARS-CoV-2 antibody. Liu Y; Tan Y; Fu Q; Lin M; He J; He S; Yang M; Chen S; Zhou J Biosens Bioelectron; 2021 Mar; 176():112920. PubMed ID: 33418184 [TBL] [Abstract][Full Text] [Related]
8. Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens. Barlev-Gross M; Weiss S; Ben-Shmuel A; Sittner A; Eden K; Mazuz N; Glinert I; Bar-David E; Puni R; Amit S; Kriger O; Schuster O; Alcalay R; Makdasi E; Epstein E; Noy-Porat T; Rosenfeld R; Achdout H; Mazor O; Israely T; Levy H; Mechaly A Anal Bioanal Chem; 2021 May; 413(13):3501-3510. PubMed ID: 33768365 [TBL] [Abstract][Full Text] [Related]
9. Development of Detection Antibody Targeting the Linear Epitope in SARS-CoV-2 Nucleocapsid Protein with Ultra-High Sensitivity. Wu F; Jiang Y; Yang H; Ma L Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674021 [TBL] [Abstract][Full Text] [Related]
10. The complexities of SARS-CoV-2 serology. Houlihan CF; Beale R Lancet Infect Dis; 2020 Dec; 20(12):1350-1351. PubMed ID: 32979317 [No Abstract] [Full Text] [Related]
11. Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips. Xie C; Ding H; Ding J; Xue Y; Lu S; Lv H J Med Virol; 2022 Apr; 94(4):1633-1640. PubMed ID: 34904253 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL). Ruetalo N; Flehmig B; Schindler M; Pridzun L; Haage A; Reichenbächer M; Kirchner T; Kirchner T; Klingel K; Ranke MB; Normann A Viruses; 2021 Nov; 13(12):. PubMed ID: 34960605 [TBL] [Abstract][Full Text] [Related]
13. Quantifying SARS-CoV-2 nucleocapsid antigen in oropharyngeal swabs using single molecule array technology. Olsen DA; Brasen CL; Kahns S; Madsen JB; Kierkegaard H; Christensen H; Jensen A; Sydenham TV; Møller JK; Madsen JS; Brandslund I Sci Rep; 2021 Oct; 11(1):20323. PubMed ID: 34645907 [TBL] [Abstract][Full Text] [Related]
15. A safe, cost-effective, and high-throughput SARS-CoV-2 antigen capture ELISA suitable for large-scale screening in low-resource settings. Singh A; Sahu U; Kulkarni PM; Yadav R; Bhatia S; Murugkar HV; Hosamani M; Basagoudanavar S; Sharma GK; Gupta PK; Kumar N; Sanyal A; Kumar N J Virol Methods; 2024 Sep; 329():114995. PubMed ID: 38972641 [TBL] [Abstract][Full Text] [Related]
16. Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study. Schaffner A; Risch L; Weber M; Thiel S; Jüngert K; Pichler M; Wohlwend N; Lung T; Ritzler M; Hillmann D; Copeland S; Renz H; Paprotny M; Risch M Clin Chem Lab Med; 2020 Nov; 59(2):e49-e51. PubMed ID: 33554502 [No Abstract] [Full Text] [Related]
17. Rapid and Quantitative Detection of Human Antibodies against the 2019 Novel Coronavirus SARS CoV2 and Its Variants as a Result of Vaccination and Infection. Taubner B; Peredo-Wende R; Ramani A; Singh G; Strle K; Cady NC Microbiol Spectr; 2021 Oct; 9(2):e0089021. PubMed ID: 34585942 [TBL] [Abstract][Full Text] [Related]
18. A sensitive gold nanoflower-based lateral flow assay coupled with gold staining technique for the detection of SARS-CoV-2 antigen. Liang R; Wang F; Li S; Niu Y; Sun Y; Hong S; Fan A Mikrochim Acta; 2024 Jun; 191(7):434. PubMed ID: 38951317 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline. Bolotin S; Tran V; Osman S; Brown KA; Buchan SA; Joh E; Deeks SL; Allen VG J Infect Dis; 2021 Apr; 223(8):1334-1338. PubMed ID: 33400794 [TBL] [Abstract][Full Text] [Related]
20. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests. De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]